ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Alcanza Clinical Research, LLC

Official 2024 U.S. DOL Form 5500 summary for Alcanza Clinical Research, LLC (Alcanza Clinical Research, LLC 401(k) Plan · EIN 87-3867885 · PN 003): $8.16M net assets, 596 active participants, and $85.29 per $10,000 (85.29 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorAlcanza Clinical Research, LLC
Filing IdentifierAlcanza Clinical Research, LLC 401(k) Plan · EIN 87-3867885 · PN 003
Plan Category & State401(k) Defined Contribution (FL)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$8.16M
Active Participants596
Direct Admin Fee Rate$85.29 per $10,000 (85.29 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderEmpower Retirement
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI